Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩74.95T | 72.3x | 2.75 | ₩1,051,000 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩39.64T | 193.1x | -2.75 | ₩186,100 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩19.99T | -4,279.7x | 42.3 | ₩392,000 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩9.73T | -47x | 0.78 | ₩72,000 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩9.01T | 60.5x | 0.57 | ₩124,800 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩9.01T | 60.5x | 0.57 | ₩109,500 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩8.23T | 0.86 | ₩106,600 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.5% Upside | Upgrade to Pro+ | ||
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩4.37T | 663.7x | 6.68 | ₩191,400 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.99T | ₩51,700 | 5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Classys Inc | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩3.93T | 43.8x | -12.5 | ₩61,300 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.3% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.73T | -1,200.5x | -13.39 | ₩103,300 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.64T | 28.3x | 0.62 | ₩330,000 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.37T | 30.4x | 1.4 | ₩335,500 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.6% Downside | Upgrade to Pro+ | |
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.35T | -101.7x | 0.38 | ₩42,750 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | |
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.07T | -12.3 | ₩245,000 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48% Upside | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.48T | -35.3x | 9.45 | ₩136,600 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.25T | 95.3x | ₩53,400 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.06T | -108.9x | 15.24 | ₩88,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩1.85T | 19.3x | 9.56 | ₩27,950 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.78T | -29.4x | 0.07 | ₩37,650 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.76T | 1.39 | ₩34,800 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.4% Upside | Upgrade to Pro+ | ||
Lunit | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩1.52T | 0.18 | ₩55,000 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.8% Upside | Upgrade to Pro+ | ||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.5T | 49.5x | 0.27 | ₩75,600 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.44T | -102.5x | 0.07 | ₩128,500 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.38T | 0.11 | ₩119,900 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.24T | -226.6x | -3.4 | ₩31,700 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.23T | 33.4x | -8.19 | ₩26,650 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.9% Upside | Upgrade to Pro+ | |
SD Biosensor | Seoul | Healthcare | Healthcare Equipment & Supplies | ₩1.21T | -21.9x | -0.21 | ₩9,900 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.14T | 37.6x | 0.03 | ₩24,650 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.11T | 14.6x | 0.09 | ₩8,960 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.04T | 6.4x | 0.14 | ₩79,300 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.03T | 25.6x | ₩36,400 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1T | -258.4x | 0.28 | ₩15,770 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩836.22B | -13.2x | 1.72 | ₩49,700 | 9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩825.77B | 78.8x | 4.96 | ₩130,700 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩818B | -68.1x | -1.32 | ₩27,500 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩803.53B | 10.6x | 0.11 | ₩9,640 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩791.64B | 2.78 | ₩19,430 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.1% Upside | Upgrade to Pro+ | ||
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩758.45B | -11.6x | ₩12,360 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩706.66B | ₩15,530 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | ₩676.93B | -31.2x | 0.06 | ₩7,990 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩665.68B | 11.3x | 0.38 | ₩15,170 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chabiotech | KOSDAQ | Healthcare | Healthcare Providers & Services | ₩640.9B | -53.3x | -4.39 | ₩11,710 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩635.45B | 11x | 0.21 | ₩99,800 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.1% Upside | Upgrade to Pro+ | |
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩628.49B | -9.8x | 0.01 | ₩13,900 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩628.49B | -9.8x | 0.01 | ₩21,600 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
T And L | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩598.94B | 15.4x | 0.5 | ₩76,300 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34% Upside | Upgrade to Pro+ | |
Won Tech Co | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩587.84B | 15.8x | -11.81 | ₩6,560 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.6% Downside | Upgrade to Pro+ | |
Jw Pharmac | Seoul | Healthcare | Pharmaceuticals | ₩549.58B | 20.6x | -0.11 | ₩22,150 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩549.58B | 20.6x | -0.11 | ₩28,100 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |